» Articles » PMID: 34439944

Use of Continuous Positive Airway Pressure (CPAP) to Limit Diaphragm Motion-A Novel Approach for Definitive Radiation Therapy for Inoperable Pleural Mesothelioma: A Pilot Study

Overview
Journal Biology (Basel)
Publisher MDPI
Specialty Biology
Date 2021 Aug 27
PMID 34439944
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant pleural mesothelioma (MPM) is a deadly disease and radiotherapy (RT) plays an important role in its management. Recent developments in technique have made it is possible to deliver RT to MPM in the intact lung. However, it is imperative to reduce normal lung doses. We present a pilot study examining the use of CPAP and VMAT radiotherapy to reduce toxicity when treating MPM, involving three consecutive patients with MPM, not amenable to surgery, who were treated according to Helsinki committee approval. Patients were simulated using four-dimentional CT simulation with the assistance of CPAP lung inflation, then were treated using both IMRT and VMAT techniques. Radiation lung dose was optimized based on accepted lung dose constraints. Patients were followed for toxicity as well as local control and survival. Results: Three patients were treated with CPAP-based IMRT treatment. These patients tolerated the treatment and DVH constraints were able to be met. The comparison plans among the four VMAT arcs and the IMRT static field treatment were able to accomplish the treatment planning objectives without significant advantages with either technique. The treatment combined with CPAP reduced the normal lung dose in MPM patients with intact lungs. This technique is worthy of further investigation.

Citing Articles

Optimizing target and diaphragmatic configuration, and dosimetric benefits using continuous positive airway pressure in stereotactic ablative radiotherapy for lung tumors.

Park J, Lee J, Chang J, Son J, Kwon S, Choi S Radiat Oncol J. 2024; 42(3):200-209.

PMID: 39354823 PMC: 11467486. DOI: 10.3857/roj.2024.00101.

References
1.
Simon M, Shochat T, Peled N, Zer A, Kramer M, Eldan O . Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesothelioma. Thorac Cancer. 2018; 9(11):1470-1475. PMC: 6209784. DOI: 10.1111/1759-7714.12860. View

2.
Rice D, Smythe W, Liao Z, Guerrero T, Chang J, McAleer M . Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2007; 69(2):350-7. DOI: 10.1016/j.ijrobp.2007.03.011. View

3.
Miles E, Larrier N, Kelsey C, Hubbs J, Ma J, Yoo S . Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience. Int J Radiat Oncol Biol Phys. 2008; 71(4):1143-50. DOI: 10.1016/j.ijrobp.2007.11.011. View

4.
Botticella A, Defraene G, Nackaerts K, Deroose C, Coolen J, Nafteux P . Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study. Strahlenther Onkol. 2017; 193(4):285-294. DOI: 10.1007/s00066-017-1108-y. View

5.
Allen A, Ceder Y, Shochat T, Fenig E, Popovtzer A, Bragilofsky D . CPAP (Continuous Positive Airway Pressure) is an effective and stable solution for heart sparing radiotherapy of left sided breast cancer. Radiat Oncol. 2020; 15(1):59. PMC: 7060550. DOI: 10.1186/s13014-020-01505-7. View